Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02574455
What this trial is testing

Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Gilead Sciences 529
Testing effectiveness (Phase 2)Study completedNCT02963493
What this trial is testing

Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Oncopeptides AB 157
Not applicableLooking for participantsNCT07514052
What this trial is testing

Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study

Who this might be right for
Multiple Myeloma of Bone
Shanxi Bethune Hospital 127
Not applicableNot Yet RecruitingNCT07805434
What this trial is testing

AI-Based Personalized Digital Management for High-Risk Pulmonary Nodule Follow-up

Who this might be right for
Pulmonary Nodules
The First Affiliated Hospital of Guangzhou Medical University 4,000
Not applicableStudy completedNCT05036863
What this trial is testing

Feasibility Study of an ePRO Monitoring for Patients With Multiple Myeloma and Development of Item Lists

Who this might be right for
Multiple Myeloma
Medical University Innsbruck 39
Testing effectiveness (Phase 2)UnknownNCT04131621
What this trial is testing

Nivolumab/Ipilimumab in Second Line CUP-syndrome

Who this might be right for
Cancer of Unknown Primary Site
University Hospital Heidelberg 194
Large-scale testing (Phase 3)Ended earlyNCT04619433
What this trial is testing

Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 48
Not applicableLooking for participantsNCT07598747
What this trial is testing

Prospective Study for the Development, Validation and Confirmation of a Multi-Cancer Early Detection Platform Through Whole-Genome Sequencing Analysis of Circulating DNA in Cancer and Non-Cancer Subjects

Who this might be right for
CancerHealthy Participants
Chang Gon Kim 6,000
Large-scale testing (Phase 3)UnknownNCT04536558
What this trial is testing

Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study

Who this might be right for
Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy
Sun Yat-sen University 352
Not applicableLooking for participantsNCT06940271
What this trial is testing

Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy

Who this might be right for
Localized Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Mayo Clinic 45
Early research (Phase 1)Study completedNCT01364844
What this trial is testing

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Solid TumorColorectal CancerEndometrial Cancer
Daiichi Sankyo 42
Large-scale testing (Phase 3)Study completedNCT04812509
What this trial is testing

Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases
Mabwell (Shanghai) Bioscience Co., Ltd. 708
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Not applicableActive Not RecruitingNCT04259398
What this trial is testing

Anesthesia and Cancer Study: Colon Cancer

Who this might be right for
Cancer of ColonAnesthesia
Seoul National University Hospital 797
Testing effectiveness (Phase 2)Study completedNCT01067287
What this trial is testing

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Beth Israel Deaconess Medical Center 35
Not applicableLooking for participantsNCT03016806
What this trial is testing

Umbilical Cord Blood Transplantation From Unrelated Donors

Who this might be right for
Acute LeukemiaImmune Deficiency DisorderCongenital Hematological Disorder+7 more
University of Rochester 30
Testing effectiveness (Phase 2)Study completedNCT01237249
What this trial is testing

Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 250
Testing effectiveness (Phase 2)Study completedNCT00916058
What this trial is testing

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 57
Large-scale testing (Phase 3)Looking for participantsNCT07297329
What this trial is testing

Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Multiple Myeloma (MM)
Sinocelltech Ltd. 292
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Next Page